New insights on chromatin modifiers and histone post-translational modifications in renal cell tumours
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New insights on chromatin modifiers and histone post-translational modifications in renal cell tumours
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume 45, Issue -, Pages 16-24
Publisher
Wiley
Online
2014-12-22
DOI
10.1111/eci.12360
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma
- (2015) Li Liu et al. BJU INTERNATIONAL
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis
- (2013) R M Silva-Santos et al. BRITISH JOURNAL OF CANCER
- Clinical and pathological impact ofVHL, PBRM1, BAP1, SETD2, KDM6A, andJARID1cin clear cell renal cell carcinoma
- (2013) Lucy Gossage et al. GENES CHROMOSOMES & CANCER
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer
- (2013) Christoph Plass et al. NATURE REVIEWS GENETICS
- Regulation of nucleosome dynamics by histone modifications
- (2013) Gabriel E Zentner et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells
- (2012) Toshihiko Sakurai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Expression and significance of histone H3K27 demethylases in renal cell carcinoma
- (2012) Yongqing Shen et al. BMC CANCER
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
- (2012) A. Ari Hakimi et al. EUROPEAN UROLOGY
- Loss of PBRM1 expression is associated with renal cell carcinoma progression
- (2012) Rafal Pawłowski et al. INTERNATIONAL JOURNAL OF CANCER
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- An overview of renal cell cancer: Pathology and genetics
- (2012) Holger Moch SEMINARS IN CANCER BIOLOGY
- The Epigenetics of Renal Cell Tumors: from Biology to Biomarkers
- (2012) Rui Henrique et al. Frontiers in Genetics
- Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma
- (2011) Sebastian Rogenhofer et al. BJU INTERNATIONAL
- A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
- (2011) John D. Hainsworth et al. CANCER INVESTIGATION
- Epigenetic biomarkers in urological tumors: A systematic review
- (2011) Carmen Jerónimo et al. CANCER LETTERS
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma
- (2011) Guangwu Guo et al. NATURE GENETICS
- The von Hippel–Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C
- (2011) X Niu et al. ONCOGENE
- Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
- (2010) Nina Wagener et al. BMC CANCER
- The VHL-dependent regulation of microRNAs in renal cancer
- (2010) Calida S Neal et al. BMC Medicine
- Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma
- (2010) Gerben Duns et al. CANCER RESEARCH
- MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis
- (2010) Shih-Ting Cha et al. CANCER RESEARCH
- Global histone acetylation levels: Prognostic relevance in patients with renal cell carcinoma
- (2010) Davit Mosashvilli et al. CANCER SCIENCE
- EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
- (2010) Börje Ljungberg et al. EUROPEAN UROLOGY
- Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma
- (2010) Jörg Ellinger et al. INTERNATIONAL JOURNAL OF CANCER
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- Global Levels of Histone Modifications Predict Prognosis in Different Cancers
- (2009) David B. Seligson et al. AMERICAN JOURNAL OF PATHOLOGY
- Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels
- (2009) D. Mahalingam et al. CLINICAL CANCER RESEARCH
- Dual Degradation of Aurora A and B Kinases by the Histone Deacetylase Inhibitor LBH589 Induces G2-M Arrest and Apoptosis of Renal Cancer Cells
- (2009) T.-L. Cha et al. CLINICAL CANCER RESEARCH
- Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1 Enhances Hypoxic Gene Expression and Tumor Growth
- (2009) A. J. Krieg et al. MOLECULAR AND CELLULAR BIOLOGY
- Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
- (2009) Gijs van Haaften et al. NATURE GENETICS
- Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
- (2008) Florian R Fritzsche et al. BMC CANCER
- Cancer treatment of the future: Inhibitors of histone methyltransferases
- (2008) Astrid Spannhoff et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF
- (2008) Sophie Beyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinomain vitroandin vivo
- (2008) Jon Jones et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors
- (2008) Lillian L. Siu et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia induces a novel signature of chromatin modifications and global repression of transcription
- (2008) Amber Buescher Johnson et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started